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Abstract 
Free cytosolic oncentrations of ATP, PCr, ADP and 5'-AMP, and the cytosolic [ATP]/[ADP].[P i ] ratio, were determined in isolated 
and in situ rat hearts using 31p-NMR spectroscopy. Total tissue metabolite concentrations were determined by HPLC analysis of 
freeze-clamped, perchloric acid-extracted tissue. In in situ myocardium the PCr/ATP ratio was 2.7 + 0.2 determined from 31p-NMR data 
(using either PCr/[3-NTP or PCr/~/-NTP), and 1.9 + 0,1 (P < 0.01) determined from total tissue concentrations. 3] P-NMR-determined 
and total tissue [PCr] were in excellent agreement (49.6 + 8.4 and 49.5 + 1.0 txmol.g -1 dry wt, respectively), whereas 31p-NMR-de- 
termined [ATP] (18.6 + 3.2 Ixmol.g-i dry wt) was only 71% of the total tissue concentration (26.1 _+ 1.7 ixmol.g i dry wt, P < 0.01). 
Isolation and Langendorff perfusion of rat hearts with glucose as substrate reduced total tissue [ATP] and [PCr] and the 3~p-NMR-de- 
termined PCr/ATP ratio fell to 1.5 + 0.1. This value agreed well with the total tissue ratio of 1.4 + 0.1, and there was excellent 
agreement between 3J P-NMR-determined and total tissue [PCr] and [ATP] values in the perfused heart. Addition of pyruvate to perfusate 
increased the 31P-NMR-determined PCr/ATP ratio to 1.7 + 0.1 due to elevated [PCr], and there remained excellent agreement between 
NMR-determined and total tissue [PCr] and [ATP] values. Free cytosolic [ADP] (from the creatine kinase equilibrium) was 5% of total 
tissue ADP, and free cytosolic [5'-AMP] (from the adenylate kinase equilibrium) ranged from 0.2-0.3% of total tissue 5'-AMP. 
Bioenergetic state, indexed by [ATP]/[ADP].[Pi], was much lower in isolated perfused hearts (30 mM -1) vs. in situ myocardium (~ 150 
mM 1). In summary, we observe a substantial disproportionality between total tissue PCr/ATP and 31P-NMR-determined PCr/ATP in 
highly energised in situ myocardium but not in isolated perfused hearts. This appears due to an NMR invisible ATP compartment 
approximating 29% of total tissue ATP in situ. Additionally, more than 95% of ADP and more than 99% of 5'-AMP exist in bound forms 
in perfused and in situ myocardium. The physiological significance of these observations i  unclear. However, substantial differences 
between 31p-NMR visible and total tissue [ATP] introduces ignificant errors in conventional estimation of free cytosolic [ADP], 
[5'-AMP] and [ATP]/[ADP].[Pi] from in vivo 31P-NMR data. 
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1. Introduction 
The question of compartmentation f myocardial ade- 
nine nucleotides has challenged scientists for a number of 
years. Conventional analyses reveal distinct compartmenta- 
tion of 5'-AMP between cytosolic and mitochondrial frac- 
tions [1,2]. Substantial differences between total and free 
cytosolic ADP may be primarily due to actomyosin bind- 
ing [!,2]. Results for ATP are more controversial, although 
evidence supports between 7-30% localisation of myocar- 
dial ATP in mitochondria [1-6]. 
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31P-NMR spectroscopy not only offers a powerful tool 
for non-invasive investigations of cellular metabolism [7,8], 
but also provides us with an alternate method of examining 
intracellular compartmentation f phosphate metabolites 
[9-11]. For example, we recently employed NMR to study 
compartmentation f phosphate and the kinetics of changes 
in free and bound phosphate in ischaemic rat heart [12]. 
However, from a methodological viewpoint compartmenta- 
tion and partial NMR visibility of nucleotides may intro- 
duce errors in 31P-NMR analysis of cellular metabolism 
and energy state. Metabolite compartmentation represents 
both a research challenge and a potential source of error 
for 31p_NMR studies. 
31P-NMR investigations of myocardial nucleotide visi- 
bility are restricted to isolated perfused hearts, and con- 
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flicting results have been obtained in this model. Humphrey 
and Garlick [10] and Bak and Ingwall [11] observe xcel- 
lent agreement between total tissue and 31p_NMR visible 
ATP under basal conditions in perfused rat hearts. Alterna- 
tively, Takami et al. calculate ATP to be only 60% NMR 
visible [9]. During ischaemia Takami et al. [9] and 
Humphrey and Garlick [10] document reductions in ATP 
visibility, whereas other groups obtain no evidence of 
changes in the NMR visibility of ATP during ischemia or 
hypoxia [11-15]. Similar controversy exists for liver where 
some studies suggest hat ATP is less than 100% NMR 
visible [16], while others indicate that NMR-determined 
and total tissue ATP values are comparable [17]. To date 
no studies have examined NMR visibility or apparent 
compartmentation f high-energy phosphates in the my- 
ocardium in situ, and few studies have addressed the 
energy state of in situ myocardium relative to the isolated 
perfused heart. Here, we address the question of high-en- 
ergy phosphate visibility or compartmentation n the in situ 
and perfused rat myocardium. 3~ P-NMR-determined ATP 
and PCr concentrations (assumed to reflect freely mobile 
cytosolic levels), and free cytosolic [ADP] and [5'-AMP] 
calculated from enzyme equilibria, are compared with 
HPLC-determined concentrations of these compounds (as- 
sumed to reflect total tissue levels). The data allows an 
assessment of the fundamental question of metabolite com- 
partmentation i the myocardium, and of the validity of 
current calibration strategies employed in in vivo 31P-NMR 
studies. 
2. Materials and methods 
2.1. Isolated perfused heart preparation 
The isovolumic Langendorff perfused rat heart prepara- 
tion used to simultaneously acquire 31P-NMR spectral and 
functional data has been described in detail previously 
[18-20]. Male Sprague-Dawley rats were anaesthetised 
with 50 mg.kg-J sodium pentobarbitone administered in- 
traperitoneally. A thoracotomy was performed and hearts 
rapidly excised into ice-cold perfusion fluid. The aorta was 
cannulated and hearts perfused via the aorta at a constant 
pressure of 100 mmHg. Perfusion fluid was a modified 
phosphate-free Krebs-Henseleit buffer containing (in mM): 
NaCI 120, NaHCO 3 25, KC1 4.7, CaC12 1.25, MgCI 2 1.2, 
glucose 15, and EDTA 0.05. In a second groups of hearts 
substrate was changed to 5 mM glucose + 10 mM pyru- 
vate. Buffer was equilibrated with 95% 0 2, 5% CO 2 and 
maintained at 37°C, giving a pH of 7.4. The left ventricle 
was vented through the apex and a fluid filled latex 
balloon introduced into the ventricle via the mitral valve. 
The balloon was attached by a fluid filled line to a Statham 
P23XL pressure transducer, and was filled using a 500-lxl 
glass syringe. For quantitation of 31p spectral intensities 
the ventricular balloon was filled with a 35 mM methylene 
diphosphonate (MDP) solution in 120 mM KC1. The MDP 
concentration was verified by atomic absorption spec- 
trophotometry. 
31P-NMR spectra were acquired at 121.46 MHz from 
isolated hearts in a 7 Tesla superconducting magnet, as 
described in detail previously [18,19]. Hearts were en- 
closed in a fluid-filled chamber and were situated within 
the sensitive volume of a double-tuned IH/3~p NMR coil. 
The magnet was initially shimmed on the heart/perfusate 
IH signal. 3Jp acquisitions employed a 10 kHz sweep 
width and consisted of 4096 data points. 
stabilisation period, 3 consecutive fully 
were acquired. The spectra consisted of 60 
FID's acquired with an interpulse delay of 
After a 30-min 
relaxed spectra 
signal averaged 
15s. 
2.2. In situ heart preparation 
Mature male Sprague-Dawley rats (420 _+ 20 g) fed ad 
libitum were used in the study. The open chest rat model 
described in detail by us previously was employed [20]. 
Briefly, the rats were initially anaesthetised with 50 
mg.kg -1 sodium pentobarbitone administered intraperi- 
toneally. Following surgical preparation, animals were 
maintained under anaesthesia by infusion of 15 
mg.kg- l.h 1 sodium pentobarbitone via the femoral vein. 
Rats were intubated and artificially ventilated using a 
Harvard small animal ventilator. 
Following instrumentation animals were placed in a 
temperature-controlled animal holder, a thoracotomy per- 
formed and a purpose built 6 mm diameter double-tuned 
surface coil with a flexible-arm was located on the left 
ventricular myocardium, as described by us previously 
[20]. The coil is positioned against he myocardium contin- 
uously throughout the cardiac cycle. Plastic film was then 
placed over the thorax to prevent heat loss and dehydration 
during the experiment. The animals were introduced into 
the horizontal bore of a 7 Tesla superconducting magnet, 
and animal temperature was continuously maintained at 
37°C by a thermostatically regulated heating jacket. Mag- 
netic field homogeneity hroughout the sample volume was 
optimised on the I H signal using a fifteen-channel Oxford 
Instruments shim supply. 
3~p-NMR spectra were acquired, without gating, at 
121.46 MHz as described in detail previously [20]. 31p 
acquisitions employed a 10-kHz sweep width and con- 
sisted of 10K data points. RF pulse-width was 53 txs and 
the square pulses were optimised to yield a maximal signal 
intensity for a 90 ° sensitive volume extending to a maxi- 
mum depth of 2.5 mm into the myocardium (see Ref. [20]). 
This procedure and small sample volume ensured minimal 
contamination from intra-ventricular blood with no con- 
tamination from adjacent tissues [20]. After a 30-min 
stabilisation period, a partially relaxed spectrum was ac- 
quired, consisting of 512 signal averaged free induction 
decays (FID's) acquired with an interpulse delay of 1.5 s. 
A fully relaxed 3Jp spectrum consisting of 512 signal 
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averaged F ID's  with a total interpulse delay of 21 s was 
then acquired, followed by a second partially relaxed 
spectrum. Initial and final spectra were acquired to assess 
metabolite stability during acquisition of the longer fully 
relaxed spectrum. F ID's  were multiplied by a Lorentzian 
line broadening factor of 25 Hz. 
To quantitate spectral intensities an external reference 
of phenylpbosphonic a id (PPA) was employed. The exter- 
nal reference consisted of a solution of 12.5 mM PPA and 
120 mM KC1 in deuterated water contained in a thin-walled 
latex balloon phantom located on the top of the NMR 
surface coil. The absolute concentration of PPA in the 
external reference was verified after experimentation by 
atomic absorption spectrophotometry. Total reference vol- 
ume (~ 1.5 ml) substantially exceeded the sensitive vol- 
ume of the coil. Thus B 1 penetration and samples volumes 
are identical within tissue and reference, permitting 
straightforward calibration of spectral intensities. In pre- 
liminary characterisation experiments heart phantoms con- 
taining known standards were alternatively placed above 
and below the surface coil with the PPA reference on the 
opposite side. This verified the B~ symmetry along the 
vertical axis (less than a 5% difference between signal 
intensities and sample volumes above and below the coil), 
and the reliability of quantitation. The accuracy and ease 
of use of similar external reference calibration strategies 
has been examined recently [21]. 
2.3. Freeze-clamp analysis of tissue metabolites 
In situ and isolated hearts were freeze-clamped in tongs 
cooled in liquid N 2 [20]. Frozen wafers were stored at 
-80°C until analysed. For analysis portions of the frozen 
tissue (~ 400 mg) were weighed, then pulverised under 
liquid N 2. The powder was added to 10 volumes of 
ice-cold 0.6 M perchloric acid and immediately ho- 
mogenised. Following brief centrifugation (2 min at 10 000 
rpm) supernatant was removed and neutralised by addition 
of 3 M KOH (to a pH of ~ 6.3). The neutralised sample 
was centrifuged and 100 [~1 of supernatant analyzed for 
PCr, Cr, ATP, GTP, CTP and UTP using the HPLC 
method of Harmsen et al. [22]. Recovery of standards 
analysed in the same manner exceeded 94%. Total ATP 
content of heparinised freshly drawn whole blood was also 
assayed (n = 4) using this HPLC method following acid 
extraction and neutralisation of samples. 
2.4. Metabolic calculations 
3~p-Spectral intensities were determined by computer 
integration of natural line-shapes. Similar results were 
obtained by fitting spectral resonances to Lorentzian line- 
shapes prior to integration. To calculate ATP concentra- 
tions from NMR data ATP was assumed to equal 93% of 
the [3-NTP (nucleoside triphosphate) intensity in isolated 
and in situ hearts based on the total tissue concentrations 
of ATP GTP, CTP and UTP (see Section 3). This assumes 
equal visibility of ATP, GTP, CTP, and UTP in 31P-NMR 
spectra. From this point [3-ATP refers to 93% of the 
[3-NTP intensity. To check that potential noise or off-reso- 
nance elements in the [3-NTP region did not significantly 
effect our data, we also calculated and compared the 
PCr/~/-NTP ratio in in situ hearts. 
3J P-NMR intensities for PCr and [3-ATP in spectra from 
in situ hearts were calibrated using the equation: 
[Metabol ite]( l~mol.g- I  ) 
= (Metabol iteIntensity/PPAIntensity) × 12.5 ~mol .g -  
Intensities for PCr and [3-ATP in fully relaxed spectra 
from isolated perfused hearts were calibrated using the 
equation: 
[Metabolite] (p~mol .g- ' )  
= (Metabol iteIntensity/MDPIntensity) × 35 I~mol.g-1 
X (Bal loonVolume/HeartVolume) 
Heart volume was determined from heart wet weight 
assuming an approximate density of 1 g.m1-1. Balloon 
volume was measured from the calibrated syringe used to 
fill the ventricular balloon. NMR-determined and HPLC- 
determined metabolite contents are converted to p~mol.g-a 
dry wt. Total tissue water and tissue dry weights were 
determined by measuring tissue weights before and after 
overnight oven drying. Tissue water contents are shown in 
Table 1. 
2.5. Calculation of.free cytosolic [ADP], [5'-AMP] and 
[A TP] / [ADPI. [Pi ] 
To examine the impact of observed nucleotide levels on 
cellular metabolic state, we calculated free cytosolic [ADP], 
[5'-AMP] and the phosphorylation ratio ([ATP]/[ADP].[P i ]) 
as described previously [20]. To calculate these indices 
tissue ATP, PCr and Cr concentrations were converted to 
mM based on the tissue water contents noted above, and 
the previously determined intracellular spaces of 40% and 
73% of total tissue water for isolated and in situ hearts, 
respectively [20]. Free cytosolic [ADP] was calculated 
from the creatine kinase equilibrium: 
[ ADP] = [ ATP] . [Cr ] / [PCr ] .K"  k 
Table 1 
Fluid compartments for in situ and Langendorff perfused rat hearts 
In situ hearts Perfused hearts 
% H20 80+ 1% wet wt 85_+2% wet wt * 
Total H20 4.0_+0.1 ml.g -I drywt 5.7_+0.2 ml.g -I drywt * 
Extracellular 1.1 ml.g- i dry wt 3.4 ml.g- I dry wt 
Intracellular 2.9 ml.g dry wt 2.3 ml.g I dry wt 
The % tissue H20 is expressed relative to total wet weight. The remain- 
ing volumes (expressed per g dry weight) are based on % tissue H20, 
and previously measured intracellular volumes of 73% and 40% for in 
situ and Langendorff perfused rat hearts upplied with glucose a sub- 
strate, respectively [20]. * P < 0.05 vs. in situ hearts. 
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where [Cr] was determined from total creatine pool ([PCr] 
+ [Cr]) values of 69.1 _+ 3.5 and 75.8 _+ 3.4 bmol.g l dry 
weight, determined by HPLC analysis of freeze-clamped 
isolated and in situ hearts, respectively, and K'ck is the 
observed creatine kinase equilibrium adjusted for experi- 
mentally measured pHa and [Mg2+]i according to the 
method of Lawson and Veech [23], but using the more 
recent dissociation constant provided in Teague and Dob- 
son [24]. [ATP]/[ADP].[P i] was calculated from the free 
cytosolic [ADP] and tissue ATP and Pi concentrations. 
Since P~ was not consistently resolvable in in situ hearts, 
we use a previously determined value of 0.83 mM [20] in 
calculating basal [ATP]/[ADP].[P i] in situ. Free cytosolic 
[5'-AMP] was determined from the adenylate kinase equi- 
librium: 
[5 ' -  AMP] = K'~.[ADp]2/[ATP] 
where K'ak is the observed adenylate kinase equilibrium 
adjusted for experimentally measured pH i and [Mg2 + ]i. 
Since basal intracellular pH cannot be measured via 
31P-NMR in situ due to poor resolution of the Pi resonance 
in the presence of blood 2,3-diphosphoglycerate, th  pH of 
7.3 determined previously for in situ rat hearts [20] was 
employed in calculating free intracellular Mg 2+ concentra- 
tions and adjustment of enzyme equilibria for in situ 
hearts. 
Free [ADP], [5'-AMP] and [ATP]/[ADP].[P i] were cal- 
culated in four different ways: (i) solely from [ATP] and 
[PCr] values determined in the 3J P-NMR experiments; (ii) 
from the HPLC determined total tissue [ATP] and the 
31 P-NMR-determined PCr/ATP ratio; (iii) from the HPLC 
determined total tissue [PCr] and the 31 P-NMR-determined 
PCr/ATP ratio; and (iv) from the HPLC determined total 
tissue values for both [ATP] and [PCr]. 
2.6. Statistics 
Data is presented as mean + S.E.M. Statistical varia- 
tions between values calculated using different methodolo- 
gies were determined using a Students t-test with Bonfer- 
roni's correction. A P-value of < 0.05 was considered 
indicative of a statistically significant difference. 
3. Results 
3. l. Total tissue phosphates determined from HPLC analy- 
sis 
HPLC analysis of freeze-clamped tissue yielded the 
nucleotide concentrations shown in Table 2. Note that 
there were only minor differences between ucleotide lev- 
els from in situ and isolated perfused hearts. ATP repre- 
sents 93% and 94% of total triphosphates analyzed (ATP, 
GTP, CTP, UTP) in in situ and isolated perfused hearts, 
respectively. Total tissue PCr was significantly higher in in 
situ compared with isolated hearts. Glucose and glucose + 
pyruvate perfused hearts displayed comparable total tissue 
ATP concentrations whereas total tissue PCr was signifi- 
cantly higher in glucose + pyruvate perfused hearts. In rat 
blood, total ATP content was calculated to be 0.6 _+ 0.2 
ixmol.ml i (n = 4). 
3.2. -~lP-NMR-determined ATP and PCr concentrations 
Typical fully relaxed 31 P-spectra cquired from in situ 
and isolated perfused rat hearts are shown in Fig. 1. Basal 
PCr/13-NTP and PCr/y-NTP ratios for in situ my- 
ocardium were calculated to be 2.48 _+ 0.42 and 2.50 +_ 
0.16, respectively, demonstrating minimal analytical differ- 
ences in this preparation when using either [3-NTP or 
y-NTP resonances. Using the 13-NTP resonance and cor- 
recting for contribution from other triphosphates 31P-NMR 
determined PCr concentrations are 1.5, 1.7 and 2.7-fold 
greater than ATP concentrations in glucose-perfused, glu- 
cose + pyruvate perfused, and in situ rat hearts, respec- 
tively (Table 2). In all models the 3~p-NMR determined 
PCr values agreed well with HPLC determined total tissue 
concentrations. In isolated perfused hearts 3~p-NMR and 
HPLC-determined ATP concentrations were also similar. 
However, in the heart in situ the 3tp-NMR determined 
ATP concentration was only 71% of the HPLC-determined 
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Fig. 1. Typical fully relaxed 31P-NMR spectra acquired from the in situ 
rat heart (upper panel) and from a Langendorff perfused rat heart supplied 
with glucose as substrate (lower panel). PPA, phenylphosphonic a id; 
MDP, methylene diphosphonate; Pi, inorganic phosphate; 2,3-DPG, 2,3- 
diphosphoglycerate; PCr, phosphocreatine; NTP, nucleoside triphosphate 
(~, ~, and [3-resonances). 
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Table 2 
Nucleotide and PCr concentrations determined by HPLC analysis of freeze-clamped tissues or from 31P-NMR data for in situ and isolated Langendorff 
perfused rat hearts 
HPLC-determined levels (total) 31P-NMR-determined levels (free) 
Isolated Isolated In situ Isolated Isolated In situ 
(Gluc) (Gluc + Pyr) (Gluc) (Gluc + Pyr) 
ATP(ixmol.g -~) 21.0_+ 1.2 21.2_+ 1.0 26.3_+ 1.4 1 19.3_+0.9(92%) 19.6_+ 1.0(92%) 18.6_+3.2 * (71%) 
PCr (Ixmol.g- ~ ) 29.4 _+ 2.3 34.0 _+ 2.1 49.8 _+ 1.5 ~" 29.0 _+ 1.8 (99%) 33.5 _+ 3.0 (98%) 49.6 5:8.4 ¢ (99%) 
PCr/ATP 1.4-+0.1 § 1.6-+0.1 1.9_+0.1 ¢ 1.5-t-0.1 § 1.7+0.1 2.7_+0.2 ~'* 
ADP(Ixmol.g -~) 4.4+0.1 § 3.6+0.1 3.3_+0.2¢ 0.20-+0.02 *§(5%) 0.16+0.02 * (4%) 0.16+0.05 * (5%) 
AMP(nmol.g - t )  920-+105§ 645-+112 510-+ 80"~ 2.16-+0.23 *§(0.2%) 1.27_+0.20 * (0.2%) 1.38_+0.48 "~* (0.3%) 
NTP (Ixmol.g- i ) 22.5 _+ 1.5 23.4 + 2.4 28.0 -+ 1.5 ¢ - - - 
[ ATP] 
(mM - I )  - - - 29-+2§ 101_+14 148_+33 * 
[ ADP ].[ Pi] 
ATP and PCr were determined by HPLC analysis (total), or using 31P-NMR methods (free cytosolic). Isolated hearts were supplied with either glucose 
(Gtuc) or glucose + pyruvate (Gluc + Pyr) as substrates. 31P-NMR-determined [ADP] and [AMP] are free concentrations calculated as outlined in Section 
2. ADP, AMP and total NTP (ATP + GTP + CTP + UTP) were determined by HPLC. % visibilities based on HPLC-determined total tissue levels are 
given in parentheses. [ATP]/[ADP].[P i] was calculated from free [ATP] and [ADP] values and NMR-determined [Pi] as outlined in Section 2. All values 
are means ± S.E.M. (n =). * P < 0.05 vs. total tissue values; t P < 0.05 vs. isolated heart values; § P < 0.05 Gluc vs. Gluc + Pyr perfused hearts. 
total tissue concentration. Consequently, while NMR and 
HPLC-determined PCr/ATP ratios were comparable for 
isolated perfused hearts (irrespective of substrate), the 
NMR determined PCr/ATP ratio for in situ myocardium 
was ~ 42% higher than the value calculated from total 
tissue concentrations (Table 2). 
Total tissue levels of ADP and 5'-AMP were much 
greater than the free cytosolic concentrations calculated 
from the creatine kinase and adenylate kinase equilibria 
(Table 2). Average K'ck values used in calculation of free 
[ADP] in glucose perfused, glucose + pyruvate perfused 
and in situ hearts were 119_7,  116+8,  and 61+3,  
respectively. Average K'ak values used in calculation of 
free [5'-AMP] in glucose perfused, glucose + pyruvate per- 
fused and in situ hearts were 1.0 + 0.1, 1.0 + 0.1, and 
0.9 + 0.1, respectively. Based on total tissue and free 
cytosolic data, we have calculated that 5% of myocardial 
ADP and 0.2-0.3% of total 5'-AMP exists in a free form 
within the myocardium of the in situ and isolated perfused 
rat heart (Table 2). 
3.3. Metabolic and bioenergetic parameters calculated 
using 31P-NMR (free) and HPLC determined (total) ATP 
and PCr values 
Owing to essentially complete NMR visibility of ATP 
and PCr in isolated perfused hearts independent of carbon 
substrate, there were no differences between metabolic and 
bioenergetic parameters calculated wholly from NMR data, 
or using total tissue [ATP] and/or [PCr] as intemal refer- 
ences (Fig. 2). On the other hand, due to the difference in 
[ATP] measured using NMR versus HPLC in the heart in 
situ, significant differences emerged in derived metabolic 
and bioenergetic parameters for the in situ myocardium 
(Fig. 2). When calculated using the common approach of 
assigning total tissue [ATP] to the 13-NTP intensity, free 
cytosolic [ADP] and [5'-AMP] values were substantially 
lower (by > 75% and 90%, respectively) than values 
calculated from the NMR-determined [ATP] and [PCr]. 
[ATP]/[ADP].[P i] was therefore significantly higher (by 
> 600%) when calculated from total tissue [ATP] rather 
than the NMR-determined concentrations (Table 2). Owing 
to excellent agreement between NMR-determined and total 
tissue PCr values, use of total tissue [PCr] as an internal 
reference did not introduce any errors in calculation of 
[ADP], [5'-AMP], or [ATP]/[ADP].[Pi]. Use of both total 
tissue [ATP] and [PCr] leads to ~ 70% overestimation f
free [ADP] and [5'-AMP], whereas [ATP]/[ADP].[P i] cal- 
culated using total tissue concentrations i  in agreement 
with the wholly NMR-determined value (Fig. 2). 
4. Discussion 
31p-NMR-spectroscopy has been an important ool in 
advancing our knowledge of cardiovascular energetics and 
metabolism over the past decade, and continues to provide 
investigators with a means of non-invasively monitoring 
intracellular metabolism. One area of continuing contro- 
versy, relevant to both myocardial metabolism and the 
application of NMR spectroscopy, is subcellular compart- 
mentation of nucleotides. As already noted, compartmenta- 
tion represents both a challenge and a potential source of 
error for 31P-NMR spectroscopy. Although 31P-NMR spec- 
troscopy is generally assumed to observe total myocardial 
ATP (and PCr) in perfused hearts, this has been questioned 
recently [9,10]. Unfortunately few studies adequately ad- 
dress the issue of NMR visibility since most fail to quanti- 
tate NMR intensities using an external reference (for ex- 
ample). Humphrey and Garlick [10] and Bak and Ingwall 
[1 1] have compared quantitation using HPLC and NMR, 
whereas other studies examine metabolite ratios or percent 
changes in metabolite levels during ischemia [12-15]. 
Moreover, no studies have compared NMR and HPLC 
quantitation of nucleotides in the in situ myocardium, 
despite the increased occurrence of in vivo studies in the 
76 J.P. Williams, J.P. Headrick / Biochimica et Biophysica Acta 1276 (1996) 71-79 
¢J 
~9 
g~ 
150 - 
120 - 
90 -  
60-  
30-  
0 
t t * 
• NM R-Determined 
[ ]  Total Tissue [ATP] Standard 
[ ]  Total Tissue [PCr] Standard 
• Total Tissue [ATP] & [Per] 
Per fused Hearts  In Situ Hear ts  
in in situ myocardium the 3~ P-NMR determined PCr /ATP  
ratio is considerably higher than the total tissue ratio. 
Assuming that 3~ P-NMR cannot observe more ATP than is 
determined by HPLC analysis of frozen tissue, this 
PCr /ATP  discrepancy in the in situ organ can only be due 
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NMR and HPLC-determined [PCr] values in isolated and 
in situ hearts; and (2) an NMR-determined [ATP] which is 
71% of the total tissue value in in situ hearts. It is 
concluded that ~ 29% of total tissue ATP is NMR invisi- 
ble in the rat myocardium in situ. 
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Fig. 2. Free cytosolic [ADP], [5'-AMP] and [ATP]/[ADP].[P~] for isolated 
Langendorff perfused hearts supplied with glucose as substrate, and in 
situ rat hearts. Values were calculated based on 3~p_NMR_determined 
PCr and ATP concentrations (NMR-Determined), HPLC-determined total 
tissue [ATP] and the NMR-determined PCr/ATP ratio (Total Tissue 
[ATP] Standard), HPLC-determined total tissue [PCr] and the NMR-de- 
termined PCr/ATP ratio (Total Tissue [PCr] Standard), and from HPLC- 
determined total tissue [ATP] and [PCr] (Total Tissue [ATP] and [PCr]). 
Values are means _+ S.E.M. (n = ). * P < 0.05 vs. 3n P-NMR-determined 
values; t P < 0.05 vs. in situ heart values. 
literature (e.g., Refs. [20,25,26]). The data presented here 
confirm recent observations of near 100% NMR visibility 
of ATP and PCr in perfused rat hearts [10,11]. In contrast, 
4.1. Compartmentation fmyocardial ATP? 
While our data support partial NMR-visibility of ATP 
in the myocardium in situ, the cellular location of this pool 
is unclear. Moreover, why ATP visibility in the in situ 
myocardium differs from that in the isolated perfused heart 
is also unknown, though several possibilities arise from 
our data. ATP does bind myofibrils [27], although it is 
generally agreed that this only accounts for 2-4% of total 
ATP. Some ATP may bind cellular ATPases and the extent 
of this binding remains to be determined. Mitochondrial 
ATP may be NMR invisible [9], possibly due to the 
proximity to paramagnetic ons [28]. This remains contro- 
versial [29]. Based on differences between total tissue 
[ATP] and NMR-determined [ATP], we estimate maximum 
possible mitochondrial ATP levels of 9% and 29% of total 
tissue ATP in isolated and in situ hearts, respectively. 
These values agree well with previous estimates of 7-30% 
[1-6,11,30]. Interestingly, previous estimates of mitochon- 
drial ATP tend to be higher in more physiological working 
heart models, consistent with a potentially higher mito- 
chondrial ATP in the myocardium in situ. In addition, 
since the in situ heart is more highly energised than the 
isolated heart, it is plausible that mitochondrial ATP is 
greater in situ. An energy-dependent decline in mitochon- 
drial [ATP] upon isolation and perfusion of the heart is 
consistent with reductions in mitochondrial [ATP] during 
severe energy depletion (e.g., ischaemia) [31,32]. More- 
over, recovery of depleted mitochondrial ATP is slow due 
to the absence of a mechanism to transport and accumulate 
cytosolic ATP into mitochondria. To examine the relation- 
ship between ATP visibility and energy state in perfused 
hearts, we supplied hearts with glucose + pyruvate as car- 
bon substrates. As shown in Table 2 addition of pyruvate 
to the buffer markedly increased [ATP]/[ADP].[Pi] ~ 3- 
fold. Nevertheless, PCr and ATP remained essentially fully 
NMR visible. Thus, there is no clear relation between 
energy state and NMR visibility. Interestingly, the magni- 
tude of the NMR invisible pool in situ equals the total 
ATP lost upon isolation and perfusion of hearts (Table 2). 
Therefore, the NMR invisible ATP may well represent the 
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entire ATP pool lost during the transition from in situ to 
isolated perfused heart. 
In addition to the energetic difference between perfused 
and in situ hearts, fluid compartmentation differs substan- 
tially (Table 1). Upon isolation and perfusion of the rat 
heart, total tissue water increases by ~ 40%, primarily 
reflecting extracellular oedema (i.e., an extracellular vol- 
ume increase of ~ 300%), together with a minor redistri- 
bution of water from the intra- to extracellular space (i.e., a 
~ 20% decline in intracellular volume). These fluid 
changes are consistent with observations of Polimeni and 
Buraczewski [33]. While they may play some role in 
modifying cellular energetics and function, these fluid 
changes are unlikely to be involved in the loss of NMR-in- 
visible ATP. Since cytosolic volume is reduced by ~ 20%, 
cytosolic solute concentrations are actually elevated. It 
seems unlikely that an increase in concentration would 
stimulate release of bound/NMR invisible ATP from 
intracellular sites. 
Another possibility deserving a mention is a contribu- 
tion to 31p-spectra from an acid-insoluble nucleotide or 
nucleotide complex. Mowbray and colleagues recently dis- 
covered and characterised a polymeric nucleotide complex 
in rat heart [34]. This is thought o represent from 25% to 
55% of the total nucleotide content of the heart. It is 
possible that such a molecule may contribute to the ~/, cx, 
and [3-P resonances in 31 P-spectra resulting in an apparent 
discrepancy between chemically determined and NMR es- 
timated ATP levels. However, the molecule's large size, 
localisation to mitochondrial membranes, and binding to 
specific phosphodiesterases [35] will limit its NMR visibil- 
ity in the heart. Moreover, despite the compound being 
present in high quantities in the perfused heart [34], the 
excellent agreement between total tissue and NMR-de- 
termined ATP for isolated hearts observed here and by 
others [10,11] argues against his possibility. It therefore 
seems unlikely that discrepancies between total tissue and 
NMR-determined ATP result from detection of this type of 
metabolite in vivo. On the other hand, it has been sug- 
gested that myocardial ATP itself is not completely acid 
extractable, with ~ 13% remaining undetected [36]. If this 
is so, the difference between perchloric acid-extracted total 
tissue ATP and 3~ P-NMR visible ATP may in fact exceed 
that observed here for isolated and in situ rat hearts. 
Finally, we exclude a significant error in analysis of in 
situ data due to a greater contribution of blood ATP in 
freeze-clamped tissue extracts versus in situ spectra. Blood 
contamination of frozen hearts can only explain less than a 
4% difference between 31P-NMR-determined and total tis- 
sue ATP contents (i.e., < 1 txmol ATP.g-l  dry weight). 
This is based on a maximal estimated blood content of 
0.3 ml.g i wet weight (i.e., vascular and ventricular 
volumes of 10% and 20%, respectively), and a measured 
blood ATP content of 0.6 i~mol.ml- 1(see Results). More- 
over, the presence of 2,3-DPG in 31p_spectra indicates that 
31P-NMR analysis does detect some of the blood signal. 
The functional significance of distinct ATP pools in the 
in situ myocardium is unclear. However, a number of 
studies support functional compartmentation of myocardial 
ATP. For example, sarcolemmal nd sarcoplasmic reticu- 
lum coupled glycolytic enzymes are capable of ATP pro- 
duction, and this ATP is preferentially utilised for mainte- 
nance of ion homeostasis [37,38]. Glycolytic ATP may 
also preferentially support ischaemic myocardium (for re- 
view, see [39]). Indeed, inconsistent relationships between 
total ATP and function during ischaemia led to the sugges- 
tion of compartmentalised ATP in cardiac muscle. Whether 
NMR invisible ATP reflects functional pools such as these 
remains to be determined. Future studies might address 
relative changes in visible and invisible ATP during is- 
chemia, as has been done in the isolated perfused heart 
[9,10]. 
4.2. Compartmentation f ADP and 5'-AMP 
In contrast o ATP, myocardial ADP and 5'-AMP are 
almost completely NMR invisible in isolated perfused and 
in situ myocardium. The currently measured ADP and 
5'-AMP compartmentation agrees well with data of Bunger 
and Soboll for perfused guinea pig hearts [1]. Cellular 
ADP is considered largely bound to actomyosin in the 
intact myocardium, and data support significant compart- 
mentation of 5'-AMP within the mitochondria [1,2]. The 
observation that less than 1% of total 5'-AMP exists freely 
in the cytosol is consistent with very low levels of 5'-AMP 
catabolites produced in normoxic myocardium despite the 
presence of highly active catabolic enzymes [1,18]. Indeed, 
100 nmol.min-l.g -1 of 5'-AMP preferring 5'-nucleo- 
tidase activity exists in the cytosol of rat myocytes [40], 
and the enzyme possesses a K m up tO 2-orders of magni- 
tude greater than the free 5'-AMP concentration. With 
respect to dephosphorylation f cytosolic 5'-AMP, the 
physiologically active catabolite adenosine is highly potent 
and only low levels are required to produce its reportedly 
important physiological ctions [18,41]. Consequently, only 
minimal levels of 5'-AMP need be exposed to cytosolic 
5'-nucleotidase [1,18]. 5'-AMP compartmentation may 
therefore balance formation of the regulatory compound 
adenosine with conservation of the myocardial nucleotide 
pool. 
4.3. Impact of compartmentation determination of bio- 
energetic indices: NMR calibration strategies 
Apart from the identity and physiological significance 
of the NMR invisible ATP compartment, i  is important to 
determine the impact of this observation on current analyti- 
cal approaches to the estimation of myocardial metabolic 
and bioenergetic state. Presently, the most common cali- 
bration strategy in in vivo NMR studies involves use of 
total tissue [ATP] as an internal reference. Total tissue 
[ATP] is equated with NMR observed 13-NTP, and [PCr] 
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and [Pi] are then determined from the 31p-NMR 
[PCr]/[ATP] and [ATP]/[P i] ratios. Alternatively, total 
tissue [PCr] may also be equated with the NMR-observed 
PCr. If myocardial ATP is not 100% NMR visible then 
these calibration strategies are all erroneous. 
Since 31p-NMR does observe essentially all ATP and 
PCr in Langendorff perfused hearts (Table 2), there are no 
substantial errors in estimation of metabolic parameters for 
the isolated heart, irrespective of the analytical approach 
taken (Fig. 2). However, in the in situ heart use of total 
tissue [ATP] and the NMR-determined PCr/ATP ratio 
results in > 75% underestimation of free cytosolic [ADP]. 
Consequently, free [5'-AMP] is underestimated by more 
than 90%, and [ATP]/[ADP].[P i] overestimated by more 
than 600% (Fig. 2). Use of both total tissue [ATP] and 
[PCr] values results in significant overestimation of free 
[ADP] and [5'-AMP], but results in a comparable estimate 
of [ATP]/ [ADP].[P i] (Fig. 2). In short, the data in Fig. 2 
show that the method yielding the greatest differences is 
currently one of the most commonly employed calibration 
strategies in in vivo and in vitro NMR studies (e.g., see 
[18,20,25,26,42]). The data indicate that without direct 
quantitation of 31p spectral intensities, total tissue [PCr] 
may in fact represent a better metabolite for calibration of 
in situ spectra than tissue [ATP]. 
5. Conclusions 
In summary, the present results demonstrate a signifi- 
cant NMR invisible ATP pool in the in situ myocardium, 
approximating 29% of total tissue ATP. On the other hand, 
our data confirm 100% NMR visibility of ATP in the 
isolated perfused heart. The physiological relevance and 
intracellular location of the invisible ATP pool in in situ 
myocardium remains to be identified. Nevertheless, the 
discrepancy between total tissue and NMR visible ATP 
introduces significant errors in metabolic indices derived 
from NMR data using current methodologies. We suggest 
that total tissue [PCr] may actually represent a better 
metabolite than [ATP] in calibrating in situ spectral data. 
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